![Natalie McNamee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Natalie McNamee
Inversor de Capital Privado en Tarnagulla Ventures Pty Ltd. .
Perfil
Natalie has been a Director of Tarnagulla Ventures Pty Ltd since 2015.
She had led the investment diligence into most of the portfolio companies since then, including Lubris BioPharma, a company which has since successfully licensed their lead indication to Novartis.
Prior to returning to Australia, Natalie worked for Tocagen Inc, a gene therapy company, based in San Diego, in their business development team whilst finishing her Masters.
She then worked as a bioengineer at the then-newly formed Quanticel Pharmaceuticals, a cancer stem cell focused drug developer.
Quanticel was acquired by Celgene for $485M in 2015.
Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.
Cargos activos de Natalie McNamee
Empresas | Cargo | Inicio |
---|---|---|
Tarnagulla Ventures Pty Ltd.
![]() Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Inversor de Capital Privado | 01/01/2015 |
Antiguos cargos conocidos de Natalie McNamee.
Empresas | Cargo | Fin |
---|---|---|
JUPITER NEUROSCIENCES, INC. | Director/Miembro de la Junta | - |
Formación de Natalie McNamee.
University of California San Diego | Graduate Degree |
University of Melbourne | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Jupiter Neurosciences, Inc.
![]() Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL. | Health Technology |
Tarnagulla Ventures Pty Ltd.
![]() Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
- Bolsa de valores
- Insiders
- Natalie McNamee